Clinical trials: Closed Loop
Pediatric Intensive Care Unit, Closed Loop Communication
Simulation Training of Closed-Loop Communication (CLC)
Open interventional before and after study on the effect of on-site full-scale simulation with a subsequent course follow-up and a three month follow-up observation pertaining to behavioural changes in communication of the…
- Conditions
- Pediatric Intensive Care Unit, Closed Loop Communication, In-situ Simulation, Behavioral Changes
- Trial name
- NCT03600298
- Testing
- Simulation
- Where
- Switzerland
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Closed Loop, Diabetes Mellitus, Type 1
Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control
The study will be conducted in crossover trial, with two 72-hour hospitalization separated by a period Wash-out of at least one week. Each hospitalization is a period of treatment.
- Trial name
- WP6-2 (NCT02627911)
- Testing
- Diabeloop System, Continuous Glucose Monitoring, Accelerometer and heart rate monitor
- Where
- 9 sites in France
- Volunteers
- 36 people
- Sponsor
- Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days., To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor.
Multiday Fully Closed Loop Insulin Delivery in Monitored Outpatient Conditions
Insulin replacement therapy is absolutely required for patients with Type 1 diabetes. The insulin pump provides for continuous subcutaneous insulin infusion (CSII), which can approximate the insulin release patterns of the normal…
- Conditions
- To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days., To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor., To Evaluate the User Experience With a Closed Loop System
- Trial name
- NCT02127827
- Testing
- Automated Ambulatory Glycemic Controller (AAGC)
- Where
- Israel
- Volunteers
- 30 people
- Sponsor
- Sheba Medical Center